Poland Appeals Against €1.1 Billion Judgment Over COVID-19 Vaccine Compensation

Poland's Ministry of Health has filed an appeal against a Brussels court's judgment, seeking to avoid paying approximately 1.3 billion euros in additional COVID-19 vaccines.

The Polish Ministry of Health recently filed an appeal against a Brussels court's judgment, requesting the court to withdraw a decision that requires the Polish government to accept and pay approximately 1.3 billion euros in additional COVID-19 vaccines developed by Fizer (Pfizer) and BioNTech.

In 2020, the Polish government signed a contract with the vaccine supplier and purchased 1.6 million doses of vaccines. However, due to reduced vaccine demand, Poland decided to stop using the vaccines and requested the supplier to return them. The supplier, on the other hand, demanded that the Polish government pay for the production cost of the vaccines.

Poland claims that the vaccine supplier breached the contract and refused to pay for the production cost of the vaccines. At the same time, the Polish government criticized the vaccine supplier for failing to timely report the expiration dates of the vaccines to the Polish government. This dispute has triggered a legal dispute between the Polish government and the European Union.

Behind the vaccine dispute, Poland's government has been concerned that the vaccine supplier's commercial behavior violated the principle of fair competition. Poland's government believes that the vaccine supplier took advantage of the Polish government's lack of knowledge to sell useless and expired vaccines. Poland's government has also requested the European Union to investigate the behavior of the vaccine supplier and to require the supplier to compensate for the losses incurred by the vaccine users.

Poland's stance on the vaccine dispute has sparked a strong reaction within the European Union. The Polish appeal will be heard by the Brussels court, and the final verdict will have a significant impact on the relationship between the Polish government and the vaccine supplier.

Regarding Poland's vaccine dispute, the European Union's spokesperson stated that the European Union will continue to support the Polish government's position and will engage in negotiations with the Polish government to resolve the vaccine dispute. The European Union will also examine the behavior of the vaccine supplier and take appropriate action to prevent similar events from happening in the future.

Poland's vaccine dispute has also attracted international attention. Germany's government spokesperson stated that the German government supports the Polish government's position and will engage in negotiations with the Polish government to resolve the vaccine dispute.

From Taiwan's perspective, this event is significant in that it highlights the possibility that vaccine suppliers' commercial behavior may violate the principle of fair competition. Poland's government stance has also sparked a strong reaction within the European Union. This event serves as a reminder that commercial behavior may have a significant impact on global health security, and Poland's government stance also demonstrates that a country has the right to supervise and investigate commercial behavior.